


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-0.76%
-0.38%
+1.44%
+1.76%
+5.21%
RDNT
RadNet
$72.90
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
RDNT Price Performance
$71.24 (+2.33%)
$78.44 (-7.06%)
$70.1 (+3.99%)
$65.47 (+11.35%)
RDNT has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

RDNT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
RDNT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RDNT Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
RDNT
RadNet
72.90
-1.67%
PPG
PPG Industries
108.57
+0.92%
OWL
Blue Owl Capital
15.60
+1.96%
EDRY
EuroDry
13.15
+3.38%
YOU
Clear Secure
33.75
-0.62%
What is RDNT current stock price?
What are RDNT stock strengths?
What is RDNT Risk Level?
What is RDNT market cap and volume?
What is RDNT current Stock IQ?
Should I buy RDNT stock right now?
Is RDNT a Strong Buy right now?
What does a 'Strong Buy' rating mean for RDNT?
What does a 'Strong Sell' rating mean for RDNT?
What factors influence RDNT's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-0.76%
-0.38%
+1.44%
+1.76%
+5.21%
RDNT
RadNet
Current Price
$72.90
RDNT Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow
Recently Viewed
RDNT
RadNet
72.90
-1.67%
PPG
PPG Industries
108.57
+0.92%
OWL
Blue Owl Capital
15.60
+1.96%
EDRY
EuroDry
13.15
+3.38%
YOU
Clear Secure
33.75
-0.62%

RDNT Price Performance
$71.24 (+2.33%)
$78.44 (-7.06%)
$70.1 (+3.99%)
$65.47 (+11.35%)
RDNT Analysts Opinion
RDNT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
RDNT Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
RDNT Street Sentiment is extremely bullish and have positive views on the near-term outlook
RDNT has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
RDNT Latest Analysis
RadNet Inc. (RDNT) Presents at 44th Annual J.P. Morgan Healthcare Conference Prepared Remarks Transcript.
Wed Jan 14, 2026
RadNet Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference January 14th 2026. LOS ANGELES Jan. 09 2026 (GLOBE NEWSWIRE) -- RadNet Inc. (NASDAQ: RDNT) a national leader in providing high-quality cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers today announced that Dr. Howard Berger President and Chief Executive Officer Mark Stolper Executive Vice President and Chief Financial Officer Dr. Gregory Sorensen Executive
Fri Jan 9, 2026
RadNet Expands to Southwest Florida with Acquisition of Radiology Regional. RadNet acquires Radiology Regional adding 13 imaging centers in Southwest Florida.
Wed Jan 7, 2026
SOFIE Biosciences Announces First Patient Dosed in [18F]FAPI-74 Phase 3 Study. First dose at RadNet in partnership with Helios Clinical and The Oncology Institute of Hope and Innovation in FAPI-GO trial for gastroesophageal cancers A second trial focused on PDAC FAPI-PRO launched December 2025 DULLES Va. Dec. 29 2025 /PRNewswire/ -- SOFIE Biosciences an...
Mon Dec 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RDNT Stock trends
RDNT Stock performance
RDNT Stock analysis
RDNT investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.